Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?-Reference-Cited by-同舟云学术

Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?

Published:2012-02-10 Issue:11 Volume:20 Page:2721-2727
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Baldotto Clarissa Seródio,Cronemberger Eduardo Henrique,de Biasi Paulo,Zamboni Mauro,Sousa Aureliano,Zukin Mauro,Small Isabelle A.,Ferreira Carlos Gil

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-012-1392-0.pdf

Reference33 articles.

1. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841

2. Chua YJ, Steer C, Yip D (2004) Recents advances in management of small-cell lung cancer. Cancer Treat Rev 30:521–543

3. Ihde DC (1992) Chemotherapy of lung cancer. N Engl J Med 327:1434–1441

4. Lassen UN, Østerlind K, Hirsch FR, Bergman B, Dombernowsky P, Hansen HH (1999) Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression. Br J Cancer 79:515–519

5. Quoix E, Hedelin G, Popin E, Charloux A, Dietemann A, Seibert R et al (1993) Can we predict very short long term survival in small cell lung cancer? Lung Cancer 10:229–238

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients;Journal of Translational Medicine;2024-06-18

2. Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3;Clinical Lung Cancer;2023-11

3. Eastern Cooperative Oncology Group Performance Status #434;Journal of Palliative Medicine;2022-03-01

4. Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid Tumors;JCO Oncology Practice;2022-01

5. Difficult Conversations and Painful Decisions: When Should Patients with Progressive Cancer Stop Chemotherapy?;Journal of Cancer Therapy;2022